Switch to:
More From Other Websites
Lemelson Capital Management CIO Discusses Ligand Pharmaceuticals Prior To Company Issuing Weak... Nov 18 2014
Ligand Provides Highlights from Today’s Analyst Day Event Nov 18 2014
LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure Nov 18 2014
Ligand/Glaxo Seek EU Nod for Severe Aplastic Anemia Drug Nov 13 2014
Ligand Partner GlaxoSmithKline Announces EU Regulatory Submission for Severe Aplastic Anemia... Nov 12 2014
Ligand Partner GlaxoSmithKline Announces EU Regulatory Submission for Severe Aplastic Anemia... Nov 12 2014
10-Q for Ligand Pharmaceuticals, Inc. Nov 03 2014
LIGAND PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Oct 31 2014
Twitter gives out 47% of its revenue in stock bonuses Oct 29 2014
Ligand Pharmaceuticals' Shares Fall on Q3 Earnings Miss Oct 29 2014
Ligand Reports Third Quarter 2014 Financial Results Oct 27 2014
Ambaraella, Pier One, Pfizer, Teva Pharmaceutical and Ligand Pharmaceuticals highlighted as Zacks... Oct 27 2014
Ligand beats Street 3Q forecasts Oct 27 2014
Ligand beats Street 3Q forecasts Oct 27 2014
LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Oct 27 2014
Ligand Reports Third Quarter 2014 Financial Results Oct 27 2014
Q3 2014 Ligand Pharmaceuticals Inc Earnings Release - Before Market Open Oct 27 2014
Ligand to Report Third Quarter 2014 Financial Results Oct 27 2014
Will Ligand Pharmaceuticals Beat Q3 Earnings Estimates? Oct 24 2014
Will Vertex Pharmaceuticals (VRTX) Post a Lower Q3 Loss? Oct 24 2014
Ligand (LGND) Shares March Higher, Can It Continue? Oct 24 2014
Why Earnings Season Could Be Great for Ligand (LGND) Oct 24 2014
Cubist Pharmaceuticals' Q3 Earnings Beat Expectations Oct 23 2014
Vertex Pharmaceuticals' Kalydeco Wins FDA Panel Backing Oct 22 2014
The Zacks Analyst Blog Highlights: Pacific Biosciences of California, Teva Pharmaceutical... Oct 22 2014
Orexigen (OREX) Shows Strength: Stock Gains 11.1% Oct 22 2014
Ligand to Host Analyst Day on November 18th in New York City Oct 16 2014
Ligand Earns $1 Million Milestone Payment Triggered by FDA Approval of Merck’s NOXAFIL®... Mar 17 2014
Ligand Announces Highlights from Presentation at the 26th Annual Roth Capital Conference Mar 11 2014
Captisol® Licensee Lundbeck Announces FDA Acceptance of NDA Submission for Carbamazepine IV Mar 10 2014
Ligand Partner GlaxoSmithKline Submits U.S. Regulatory Application for Promacta® (eltrombopag) for... Feb 28 2014
Ligand to Present at the 26th Annual Roth Conference on March 11 Feb 28 2014
Ligand Reports Fourth Quarter and Full Year 2013 Financial Results Feb 11 2014
Ligand to Receive $1 Million Kyprolis® Commercial Milestone Payment from Onyx Pharmaceuticals Feb 10 2014
Ligand, Glaxo drug gets special FDA designation Feb 03 2014
Ligand Partner GlaxoSmithKline Gains FDA Breakthrough Therapy Designation for Promacta®/Revolade®... Feb 03 2014
Ligand to Report Fourth Quarter Results on February 11th Jan 29 2014
Ligand Raises Fourth Quarter and Full Year 2013 Financial Forecast Dec 09 2013
Ligand Announces Positive Preclinical Data on Small-Molecule G-CSF Receptor Agonist at the 55th... Dec 09 2013


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK